Cognitive performance is not a single faculty. It is a composite of working memory, processing speed, sustained attention, executive function, and neurochemical integrity — each with its own substrate, each susceptible to different nutritional inputs. I have spent considerable time reviewing the peer-reviewed literature on this topic, and what strikes me most is how far the popular conversation has drifted from the evidence. Supplement marketing promises the world; the controlled trials are considerably more modest, more nuanced, and — for that reason — far more interesting.
This guide covers what the research currently supports regarding nutrition, specific compounds, and cognitive performance across the adult lifespan. I have restricted myself to published, peer-reviewed evidence. Where the data are weak, I say so. Where EFSA has approved specific health claims, I cite the register. Where a compound appears in KōJō Daily Formula, I note the exact dose and what the evidence says about it.
The reader I am writing for has already dismissed the influencer stack. They want mechanisms, trial data, and honest caveats. That is what follows.
Why Cognitive Performance Declines — and What Nutrition Has to Do With It
Before discussing what might support cognitive performance, it is worth understanding the biological terrain. Cognitive decline is not a single process. It involves synaptic loss, neuroinflammation, mitochondrial dysfunction, oxidative stress, impaired neurotransmitter synthesis, and — in more severe cases — amyloid and tau pathology.
A landmark single-cell transcriptomic study published in Nature mapped these processes across six brain regions in 283 post-mortem human brains, identifying distinct cellular trajectories in individuals with and without Alzheimer's neuropathology. The findings confirmed that cognitive resilience is not simply the absence of pathology — it is an active biological state involving specific cellular mechanisms. Mathys 2024
Separately, research into individuals who remain cognitively intact despite presenting histopathological signs of Alzheimer's disease — termed "nondemented with AD neuropathology" (NDAN) — has shed light on what protective mechanisms might look like at a cellular level. Microglial activation patterns and phosphatidylserine signalling appear to play a role in maintaining synaptic integrity even in the presence of amyloid burden. Fracassi 2023
What this tells us is that the nutritional levers we pull are not operating on a blank slate. They interact with a complex, dynamic system. The question is not "does nutrition affect cognition?" — it plainly does — but rather which specific inputs, at which doses, have sufficient evidence to warrant inclusion in a serious cognitive health protocol.
Omega-3 Fatty Acids: The Most Studied Nutritional Lever
Docosahexaenoic acid (DHA) is structurally integral to neuronal membranes. It comprises a substantial proportion of the brain's grey matter lipid content, and its availability influences membrane fluidity, synaptic signalling, and neuroinflammatory regulation. The evidence base here is among the most developed in nutritional neuroscience.
A systematic review and meta-analysis examining omega-3 supplementation — including DHA and EPA — in the context of cognitive decline found meaningful signals, particularly in populations with early-stage impairment. The analysis noted that omega-3 supplementation was associated with slowed cognitive decline in Alzheimer's patients, though effects were more pronounced in earlier disease stages. Calderon 2024
Prospective cohort data add further texture. A longitudinal analysis drawing on 1,135 participants from the Alzheimer's Disease Neuroimaging Initiative found that both dietary omega-3 intake and blood biomarkers of omega-3 status were associated with reduced risk of cognitive decline over time. The relationship held after adjustment for confounders, suggesting it is not simply a proxy for overall dietary quality. Wei 2023
A narrative review in Current Opinion in Lipidology reached a similarly cautious but positive conclusion: higher omega-3 intake and blood levels are associated with better cognitive outcomes, though the authors noted that randomised controlled trial data remain heterogeneous and that timing of intervention — earlier rather than later — appears to matter considerably. Welty 2023
It is worth noting that the form of DHA matters for bioavailability and sustainability. Algal DHA — derived from the microalgae that fish themselves consume — provides the same molecular form as marine sources without the environmental and contamination concerns associated with fish oil. The evidence for DHA's role in neuronal membrane integrity does not distinguish between marine and algal sources; the molecule is the same.
Choline: The Neurotransmitter Precursor That Most People Under-Consume
Acetylcholine is the primary neurotransmitter of attention, memory consolidation, and executive function. Its synthesis depends directly on choline availability. Despite this, choline is one of the most consistently under-consumed essential nutrients in Western diets — a fact that has significant implications for cognitive health across the lifespan.
A cross-sectional analysis of older US adults from the National Health and Nutrition Examination Survey found that higher dietary choline intake was associated with significantly better cognitive performance on standardised assessments. The relationship was dose-dependent and remained significant after adjustment for age, sex, education, and overall dietary quality. An 2023
A comprehensive review of choline supplementation forms — including choline bitartrate, alpha-GPC, and citicoline — confirmed that cholinergic compounds function as precursors to acetylcholine and phosphatidylcholine, with downstream effects on neuronal membrane integrity and neurotransmitter availability. Kansakar 2023
A systematic review and meta-analysis of choline alphoscerate (alpha-GPC) specifically found significant improvements in cognitive function impairment in neurological conditions including adult-onset dementia, with the authors noting its well-established mechanism of action through cholinergic pathway support. Sagaro 2023
EFSA's NHC register approves the wording "choline contributes to normal homocysteine metabolism" and "choline contributes to the maintenance of normal liver function" — though it does not currently carry an approved claim specifically for cognitive performance, the mechanistic pathway through acetylcholine synthesis is well-established in the literature cited above.
Bacopa Monnieri: The Adaptogen With Genuine Trial Data
Bacopa monnieri occupies an unusual position in the cognitive supplement landscape: it is an Ayurvedic herb with a centuries-long history of use as a memory and learning enhancer that also has a reasonable body of modern controlled trial evidence behind it.
A detailed pharmacological review published in Frontiers in Nutrition examined both the phytochemical profile of Bacopa monnieri extract (BME) and its clinical evidence base. The active compounds — bacosides — appear to exert effects through multiple mechanisms: antioxidant activity, modulation of acetylcholine synthesis, reduction of beta-amyloid accumulation in preclinical models, and anti-inflammatory signalling. The review noted positive signals in clinical studies on memory and learning, with the caveat that study populations and outcome measures vary considerably across trials. Fatima 2023
A broader narrative review of twenty-one nutrients and phytonutrients on cognitive function, published in the Journal of Clinical and Translational Research, included Bacopa among the compounds with the most consistent evidence for memory-related outcomes, noting its particular relevance for delayed recall and information processing speed. Lewis 2023
The standard caveat applies: most Bacopa trials are relatively short (8–12 weeks), conducted in specific populations, and use varying extract concentrations. The evidence is encouraging but not definitive. What can be said with reasonable confidence is that Bacopa monnieri extract, at doses used in clinical trials, appears to support memory-related cognitive outcomes in a manner consistent with its proposed cholinergic and antioxidant mechanisms.
Phosphatidylserine and Membrane Integrity
Phosphatidylserine (PS) is a phospholipid concentrated in neuronal membranes, where it plays a structural role and participates in signal transduction. It is one of the few cognitive supplements to have attracted serious randomised controlled trial attention in human populations.
A randomised, double-blind, placebo-controlled trial conducted in Chinese older adults with mild cognitive impairment found that a supplement containing phosphatidylserine and alpha-linolenic acid produced significant improvements in cognitive function compared to placebo over the trial period. The authors proposed that the combination effects operated through membrane stabilisation and modulation of neuroinflammatory pathways. Duan 2024
The cellular biology underpinning this is illuminating. Research into NDAN individuals — those who maintain cognitive function despite Alzheimer's neuropathology — found that exposed phosphatidylserine on neuronal surfaces acts as a signal mediating microglial-driven synaptic maintenance. The implication is that phosphatidylserine availability may influence not just membrane structure but active neuroprotective signalling. Fracassi 2023
The US FDA has allowed a qualified health claim for phosphatidylserine and cognitive dysfunction, noting that "very limited and preliminary scientific research suggests that phosphatidylserine may reduce the risk of dementia in the elderly." The qualification is important — the evidence is real but the effect size is modest and the population studied matters considerably.
Hericium Erinaceus: Nerve Growth Factor and the Neurotrophin Angle
Lion's mane (Hericium erinaceus) has attracted significant research interest in recent years, primarily because of its apparent capacity to stimulate nerve growth factor (NGF) synthesis — a neurotrophin essential for the maintenance and survival of neurons.
A 2023 review in the International Journal of Molecular Sciences summarised the neurotrophic and neuroprotective effects of H. erinaceus, noting that its active compounds — erinacines (from mycelia) and hericenones (from fruiting bodies) — stimulate NGF release, modulate neuroinflammation, reduce oxidative stress, and appear to protect neurons from apoptosis in preclinical models. Szućko-Kociuba 2023
A systematic review focused specifically on erinacines — the cyathane diterpenoids found in H. erinaceus mycelia — confirmed their role in mediating neuroprotective effects across multiple preclinical models, noting mechanisms including NGF induction, anti-neuroinflammatory activity, and modulation of amyloid precursor protein processing. Spangenberg 2025
A narrative review considering H. erinaceus in the context of Alzheimer's disease prevention noted that while human trial data remain limited, the preclinical mechanistic evidence is unusually robust for a botanical compound, and the safety profile appears favourable. The authors called for larger, longer human trials. Cornford 2025
I want to be direct about the state of the evidence here: the human trial data for H. erinaceus are limited in scale and duration. The preclinical mechanistic picture is compelling. The honest position is that this is a compound worth watching closely, with a plausible mechanism and an early but encouraging human signal — not a proven cognitive intervention.
Magnesium, B Vitamins, and the Infrastructure of Cognitive Function
Some nutritional inputs to cognitive performance operate not through dramatic acute effects but through the maintenance of basic neurochemical infrastructure. Magnesium and the B vitamin complex fall into this category — and their importance is frequently underestimated precisely because their effects are foundational rather than spectacular.
Magnesium is involved in over 300 enzymatic reactions, including those governing synaptic plasticity, NMDA receptor function, and neuronal excitability. A double-blind, placebo-controlled trial of a magnesium L-threonate-based formula in healthy Chinese adults found significant improvements in cognitive function across multiple domains, with the authors attributing the effect to the compound's superior ability to raise brain magnesium levels compared to other magnesium forms. Zhang 2022 EFSA's NHC register approves the wording "magnesium contributes to normal functioning of the nervous system" and "magnesium contributes to normal psychological function."
B vitamins — particularly B6, B12, folate, and B1 — are essential cofactors in neurotransmitter synthesis, homocysteine metabolism, and myelin maintenance. Elevated homocysteine is consistently associated with accelerated cognitive decline and increased dementia risk. EFSA's NHC register approves claims that B6, B12, and folate "contribute to normal homocysteine metabolism," and that B1, B6, and B12 "contribute to normal functioning of the nervous system."
A broad narrative review of twenty-one nutrients and phytonutrients on cognitive function confirmed the centrality of B vitamin status to cognitive health, noting that deficiencies — even subclinical ones — are associated with measurable cognitive impairment, and that supplementation in deficient populations produces meaningful improvements. Lewis 2023
A review of over-the-counter supplements for memory noted that the evidence for B vitamins is strongest in populations with documented deficiency or elevated homocysteine, and more modest in replete populations — a finding consistent with the general principle that nutritional interventions tend to show larger effects where baseline status is poor. Hersant 2023
What the Evidence Does Not Support
Intellectual honesty requires saying this clearly: a substantial portion of the cognitive supplement market is not supported by credible human trial evidence. Several compounds that dominate online discussions — certain nootropic racetams, high-dose single antioxidants, and various proprietary "brain blend" formulations — lack adequate randomised controlled trial data in healthy adult populations.
The review of over-the-counter memory supplements published in CNS Drugs was particularly frank on this point, noting that the market size — valued at US$7.6 billion in 2021 and projected to reach US$15.59 billion by 2030 — vastly outpaces the evidence base supporting most products within it. The authors found that evidence quality was highly variable, with many widely-sold compounds lacking rigorous human trial data. Hersant 2023
This does not mean the field is without merit. It means that compound selection, dose, form, and the quality of the underlying evidence all matter enormously. The difference between a serious cognitive health protocol and a marketing exercise is whether the formulator has read the primary literature or the distributor's sell sheet.
Several principles emerge from a careful reading of the evidence:
- Baseline nutritional status matters. Interventions in deficient or insufficient populations consistently show larger effects than those in well-nourished populations. Correcting a deficiency is not the same as achieving a performance enhancement above baseline. - Timing and duration matter. Many cognitive interventions show effects only after several weeks of consistent use. Acute single-dose studies are poor predictors of real-world utility. - Combination effects are understudied. Most trials examine single compounds. The interactions between multiple nutritional inputs — positive or negative — are not well characterised. - Population specificity matters. Evidence from older adults with mild cognitive impairment does not automatically translate to healthy 35-year-olds, and vice versa.
What KōJō Daily Formula Does for Cognitive Performance
KōJō Daily Formula v4.1 was formulated with the above evidence landscape in mind. Below are the ingredients most directly relevant to cognitive performance, with their exact doses and the evidence rationale for each.
Algal DHA — 250mg Provides the primary structural fatty acid of neuronal membranes. Prospective cohort data associate higher DHA status with reduced cognitive decline risk. Wei 2023 Algal-derived, providing the same molecular form as fish-sourced DHA.
Choline Bitartrate — 1000mg Precursor to acetylcholine, the neurotransmitter of attention and memory consolidation. Cross-sectional data link higher choline intake to better cognitive performance in older adults. An 2023 EFSA's NHC register approves the wording "choline contributes to normal homocysteine metabolism."
Bacopa Monnieri Extract — 300mg Contains bacosides supporting memory-related cognitive outcomes through cholinergic modulation and antioxidant activity. Clinical trial data show positive signals for delayed recall and processing speed. Fatima 2023
Magnesium Bisglycinate — 1000mg (200mg elemental) Supports synaptic plasticity and NMDA receptor function. EFSA's NHC register approves "magnesium contributes to normal functioning of the nervous system" and "magnesium contributes to normal psychological function." Bisglycinate form selected for superior gastrointestinal tolerability.
Vitamin B12 — 500mcg Essential cofactor in neuronal maintenance and homocysteine metabolism. EFSA's NHC register approves "vitamin B12 contributes to normal functioning of the nervous system" and "vitamin B12 contributes to normal psychological function."
Folate — 400mcg Works alongside B12 in homocysteine metabolism. EFSA's NHC register approves "folate contributes to normal psychological function."
Vitamin B6 — 2.8mg Cofactor in neurotransmitter synthesis including serotonin and dopamine. EFSA's NHC register approves "vitamin B6 contributes to normal functioning of the nervous system" and "vitamin B6 contributes to normal psychological function."
Vitamin B1 — 2.2mg Essential for cerebral glucose metabolism. EFSA's NHC register approves "thiamine contributes to normal functioning of the nervous system" and "thiamine contributes to normal psychological function."
L-Theanine — 200mg Found naturally in green tea. Evidence suggests it supports calm, focused attention, particularly in combination with caffeine. The matcha in the formula (2000mg) provides both L-theanine and a modest caffeine content, making this a synergistic pairing with a reasonable evidence base. Lewis 2023
Rhodiola Rosea Extract — 350mg An adaptogenic herb with evidence suggesting it supports mental performance under fatigue and stress. Evidence is limited compared to the compounds above, but the safety profile is favourable and the mechanistic rationale — stress hormone modulation and mitochondrial support — is plausible.
N-Acetyl Cysteine — 600mg Precursor to glutathione, the primary endogenous antioxidant. Neuroinflammation and oxidative stress are established contributors to cognitive decline. NAC's role in supporting antioxidant capacity is well-characterised, though direct cognitive trial data in healthy populations are limited.
Vitamin D3 — 50mcg Vitamin D receptors are expressed throughout the brain. EFSA's NHC register approves "vitamin D contributes to normal functioning of the immune system." Evidence for cognitive-specific effects is growing but not yet at the level of the compounds above. Given the prevalence of vitamin D insufficiency in the UK population, inclusion at this dose is well-justified.
Iodine — 150mcg EFSA's NHC register approves "iodine contributes to normal cognitive function" and "iodine contributes to normal functioning of the nervous system." Iodine deficiency is the leading preventable cause of cognitive impairment globally.
Matcha Green Tea Powder — 2000mg Provides L-theanine, EGCG (a polyphenolic antioxidant), and a modest caffeine content. The L-theanine/caffeine combination has the most consistent acute cognitive evidence of any dietary pairing in the literature. Lewis 2023
The honest summary of the cognitive performance evidence landscape is this: several nutritional inputs have genuine, peer-reviewed support for their roles in maintaining cognitive function, supporting neurotransmitter synthesis, and reducing the biological processes associated with cognitive decline. None of them are miraculous. Most work best when baseline status is inadequate — which, given the nutritional profile of the average Western diet, is more common than most people assume.
The case for a well-formulated, evidence-led daily supplement is not that it will dramatically alter cognitive performance in a well-nourished individual in the short term. It is that the biological infrastructure of cognition — membrane integrity, neurotransmitter availability, mitochondrial function, neuroinflammatory regulation — depends on a consistent supply of specific nutrients, and that gaps in that supply have measurable consequences over time.
The research supports building that foundation carefully, consistently, and with appropriate scepticism about any claim that exceeds what the evidence actually shows.
Frequently Asked Questions
Why does the timing of omega-3 supplementation seem to matter so much for cognitive outcomes?
Earlier intervention appears more effective than later intervention. Prospective cohort data suggest omega-3 status is associated with reduced decline risk, but randomised trials show more pronounced effects in early-stage impairment rather than advanced disease. The mechanism likely involves preventing initial synaptic loss rather than reversing established pathology.
I'm already eating reasonably well — do I actually need choline supplementation if I'm not deficient?
Most Western adults are chronically under-consuming choline despite it being essential for acetylcholine synthesis. Cross-sectional data link higher intake to better cognitive performance in older adults. Whether supplementation benefits those meeting baseline requirements remains unclear; the evidence supports addressing under-consumption rather than megadosing.
How confident should I be in Bacopa monnieri given it's an herbal supplement?
Bacopa has genuine controlled trial evidence supporting memory and processing speed outcomes, which is more than most herbal supplements can claim. However, most trials are short (8–12 weeks), use varying extract concentrations, and study specific populations. The evidence is encouraging but not definitive — it's a reasonable candidate, not a proven intervention.
What's the actual difference between algal and fish-derived DHA for my brain?
None. The molecule is identical. Algal DHA provides the same neuronal membrane benefits as marine sources without environmental concerns or fish oil contamination risks. Choose based on sustainability and personal preference; the cognitive mechanism does not distinguish between sources.
Does phosphatidylserine actually do anything, or is it just membrane padding?
It appears to do more than structural work. Recent research suggests phosphatidylserine on neuronal surfaces signals microglial-driven synaptic maintenance, particularly in individuals maintaining cognition despite Alzheimer's pathology. A recent randomised trial showed cognitive improvements with phosphatidylserine supplementation in mild impairment, though the mechanism involves active neuroprotection, not just membrane padding.
